Acuña, Rechelle .
HRN: 22-00-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2022
CEFUROXIME 500MG (TAB)
09/25/2022
10/01/2022
PO
500mg
BID
S/P RMLE Repair
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes